Do manufacturers provide private labeling
While they are not yet available for use, research is underway that could eventually bring these therapies into mainstream care
OP successfully prevents increases in arterial ammonia while evidence exists from animal models suggesting a significant decrease in extracellular brain ammonia, preventing intracranial hypertension and improving the mental state (mechanism of action summarized in Fig
J.CoombesA
Advanced (Weeks 9-12) Dose : 500 mcg subQ (split 250 mcg AM/PM) Frequency : Twice daily Duration : 8-12 weeks, monitored For metabolic resistance
Cornel JH, Bakris GL, Stevens SR, Alvarsson M, Bax WA, Chuang LM, Engel SS, Lopes RD, McGuire DK, Riefflin A, Rodbard HW, Sinay I, Tankova T, Wainstein J, Peterson ED, Holman RR